PREVALENCE OF MORTALITY FROM COVID-19 IN PREGNANT WOMEN WITH ASTHMA (2020 TO 2023)
Article Sidebar
Main Article Content
Abstract
COVID-19 is an infectious disease caused by the SARS-CoV-2 coronavirus, first identified in Wuhan, China, in late 2019. Characterized by rapid spread among people, the disease spread rapidly across several countries, being classified as a pandemic by the World Health Organization (WHO) and declared a Public Health Emergency of International Concern. The objective of this study is to describe the mortality profile in pregnant women living with asthma diagnosed with COVID-19 in the period 2020-2023. The data were obtained through the Influenza Epidemiological Surveillance Information System (SIVEP-Gripe), collecting cases of Severe Acute Respiratory Syndrome (SARS) in pregnant women, referring to the year 2020 to 2023, describing the entire national territory. 88 pregnant women living with asthma were reported in the period. After inserting the survival analysis, it was observed that deaths occurred with a higher probability in the first trimester 18.7%, followed by 67% in the second trimester and 315% in the third trimester. Thus, it is possible to associate a greater probability of death in the first trimester of pregnancy, which may have coincided with the non-identification of the disease and worsening of symptoms. After carrying out the study, it was concluded the importance of prenatal care and asthma as a comorbidity that may compromise the expectancy and quality of life of the pregnant woman.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c). Conjuncture Bulletin (BOCA)
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
ABREU, L. C. et al. “A time-series ecological study protocol to analyze trends of incidence, mortality, lethality of COVID-19 in Brazil”. Journal of Human Growth and Development, vol. 31, n. 3, 2021.
BHAGAVATHULA, A. S. “The Impact of COVID-19 on Mortality in Italy: Retrospective Analysis of Epidemiological Trends”. JMIR Public Health and Surveillance, vol. 8, 2022.
BRASIL. “Covid-19: situação epidemiológica do Brasil até a SE 10 de 2023”. Gov.br [2023]. Disponível em: . Acesso em: 12/02/2025.
BRASIL. Coronavírus Brasil. Brasília: Ministério da Saúde, 2024. Disponível em: . Acesso em: 23/02/2025.
BRIOZZO, L. et al. “Inequidades socioeconómicas en los resultados sanitarios durante la emergencia sanitaria por pandemia COVID-19 en Uruguay”. Revista Médica del Uruguay, vol. 41, n. 1, 2025.
BRITO, S. A. et al. “Three years of COVID-19 pandemic: comparative analysis of incidence, lethality and mortality among the States of the south region of Brazil”. Journal of Human Growth and Development, vol. 33, n. 3, 2023.
CALABRO, G. E. et al. “The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence”. Vaccines, vol. 11, n. 5, 2023.
CALLAWAY, E. “COVID’s future: mini-waves rather than seasonal surges”. Nature, vol. 617, 2023.
FREITAS, C. M. et al. Covid-19 no Brasil: cenários epidemiológicos e vigilância em saúde. Rio de Janeiro: FIOCRUZ, 2021.
IEE Security and Privacy, vol. 6, 2023.
LUCENA FILHO, R. B. et al. “Blockchain e sua influência na qualidade das informações contábeis: uma análise bibliométrica. Boletim de Conjuntura (BOCA), vol. 21, n. 61, 2025.
MAIA, P. C. G. G. S. et al. “Space-temporal analysis of the incidence, mortality and case fatality of COVID-19 in the State of Rio Grande do Norte, in the period from 2020 to 2022, in the Northeast of Brazil”. Journal of Human Growth and Development, vol. 24, n. 1, 2024.
MOOLA, I.; HILAMO, H. “Health system characteristics and COVID-19 performance in high income countries”. BMC Health Services Research, vol. 23, n. 1, 2023.
MOURA, E. C. et al. “Covid-19: evolução temporal e imunização nas três ondas epidemiológicas, Brasil, 2020–2022”. Revista de Saúde Pública, vol. 56, 2022.
MURALIDAR, S. et al. “The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2”. Biochimie, vol. 179, 2020.
OPAS - Organização Pan-Americana da Saúde. “Histórico da pandemia de COVID-19”. OPAS [2020]. Available in: . Access in: 12/01/2025.
OPAS - Organização Panamericana da Saúde. Covid-19 Health Care Workers Study (HEROES): Rela tório Regional das Américas. Geneva: OPAS, 2022. Disponível em: . Acesso em: 12/03/2025.
PAPANDRIA, P. J. “Blockchain e Contabilidade: Aplicação de um Novo Modelo de Registro de Dados com sua Imutabilidade”. Revista e-Locução, vol. 1, n. 24, 2023.
ROVEITTA, A. B. et al. “COVID-19 vaccination in pregnancy and lactation: current research and gaps in understanding”. Frontiers in Cellular and Infection Microbiology, vol. 11, 2021.
SIQUEIRA, T. S. et al. “Spatial clusters, social determinants of health and risk of maternal mortality by COVID-19 in Brazil: a national population-based ecological study”. The Lancet Regional Health - Americas, vol. 3, 2021.
SOEIRO, E. M. D. et al. “The challenges of the pandemic and the vaccination against covid-19 in pediatric patients with kidney disease”. Brazilian Journal of Nephrology, vol. 45, n. 2, 2023.
TAREQ, A. M. et al. “Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic”. Human Vaccines and Immunotherapeutics, vol. 17, n. 11, 2021.
TAYLOR, L. “We are being ignored”: Brazil’s researchers blame anti-science government for devastating COVID surge. Nature, vol. 593, n. 7857, 2021.
WANG, J. “Research on the construction of accounting information audit quality control system based on blockchain”. ResearchGate [2024]. Disponível em: . Acesso em: 23/02/2025.
WATSON, O. J. et al. “GLOBAL impact of the first year of CO VID-19 vaccination: a mathematical modelling study”. The Lancet Infectious Diseases, vol. 22, n. 9, 2022.
WHO - World Health Organization. Coronavirus disease (COVID-19). Geneva: WHO, 2020. Available in: . Access in: 12/02/2025.